As an investor, one of the most powerful tools I have is a Stocks and Shares ISA. With £20k of tax-free investing available annually, it’s possible to build some serious long-term wealth! I’ve been keeping cash ready for the right opportunity, but these three companies have me convinced.
Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.
GigaCloud Technology
GigaCloud Technology (NASDAQ:GCT) is one of the stocks I’m most excited about at the moment. The company provides end-to-end e-commerce solutions for large parcel distribution. Not exactly an exciting sector, but the numbers speak for themselves. GigaCloud turned profitable this year, and with earnings expected to grow by 21% per year, this could be a tremendous opportunity.
An investment in GigaCloud, alongside many China-based companies, is not for the faint-hearted. With an average move of 13% per week, this is a volatile one. This can be attributed to macro-economic fears around investing in China, as well as supply chain issues. However, with such strong fundamentals, I’d expect the long-term outcome to be positive. The price-to-earnings (P/E) ratio is well below the average of the sector. By considering the future cash flow, a fair value of $430.85 is calculated. As a result, the shares could be as much as 98% undervalued!
Doximity
Doximity (NYSE:DOCS) operates a cloud-based digital platform for medical professionals in the US. The share price has tumbled in the last few years as user growth has slowed, and profit margins have reduced.
However, the company is now looking to be in bargain territory for my Stocks and Shares ISA. A discounted cash-flow calculation indicates Doximity may be as much as 49% undervalued. With earnings still growing at a healthy 19% per year, I like the look of this company for a long-term investment. At a P/E ratio of 37 times, it is far below the average of the medical software sector at 71 times. The company has no debt and strong fundamentals, which is ideal in a time of high interest rates and uncertainty. The shrinking profit margins will be a concern for many investors, but with over 80% of doctors in the US verified members of the platform, this looks to be a company with staying power.
Future
Future (LSE:FUTR) develops and distributes content for games, entertainment, and news in the US and UK. The share price has fallen by over 50% in the last year as investors were concerned about the company’s debt levels, and uncertain advertising revenues.
Concerns about the near-term debt levels are valid, but looking long-term, the company seems to be in fairly good shape. The company’s P/E ratio of 8.1 times is well below the sector average of 11.1, albeit with lower growth. The expected growth rate of 8.1% won’t turn many heads, but I don’t mind steady growth if the company is undervalued over the long term. My interest peaks when looking at the discounted cash-flow calculation, indicating a potential 70% upside to the fair value of £26.35. With advertising looking likely to remain a lucrative and valid part of the market, I like the look of this company.
The plan
These companies all have terrific potential for my Stocks and Shares ISA, but they’re by no means a sure thing. I’m taking the appropriate steps to diversify across a range of asset classes, sectors, and risk profiles.
